Search

Your search keyword '"Co, Ngai Na"' showing total 37 results
Start Over Author "Co, Ngai Na" Publisher american association for cancer research (aacr)
37 results on '"Co, Ngai Na"'

1. Supplementary Figure 1 from Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy

Author

Iglesias, David A., primary, Yates, Melinda S., primary, van der Hoeven, Dharini, primary, Rodkey, Travis L., primary, Zhang, Qian, primary, Co, Ngai Na, primary, Burzawa, Jennifer, primary, Chigurupati, Sravanthi, primary, Celestino, Joseph, primary, Bowser, Jessica, primary, Broaddus, Russell, primary, Hancock, John F., primary, Schmandt, Rosemarie, primary, and Lu, Karen H., primary

Published
2023
Full Text
View/download PDF

2. Supplementary Figure Legend from Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy

Author

Iglesias, David A., primary, Yates, Melinda S., primary, van der Hoeven, Dharini, primary, Rodkey, Travis L., primary, Zhang, Qian, primary, Co, Ngai Na, primary, Burzawa, Jennifer, primary, Chigurupati, Sravanthi, primary, Celestino, Joseph, primary, Bowser, Jessica, primary, Broaddus, Russell, primary, Hancock, John F., primary, Schmandt, Rosemarie, primary, and Lu, Karen H., primary

Published
2023
Full Text
View/download PDF

3. Supplementary Figure 1 from Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy

Author

Iglesias, David A., primary, Yates, Melinda S., primary, van der Hoeven, Dharini, primary, Rodkey, Travis L., primary, Zhang, Qian, primary, Co, Ngai Na, primary, Burzawa, Jennifer, primary, Chigurupati, Sravanthi, primary, Celestino, Joseph, primary, Bowser, Jessica, primary, Broaddus, Russell, primary, Hancock, John F., primary, Schmandt, Rosemarie, primary, and Lu, Karen H., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Figure 2 from Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy

Author

Iglesias, David A., primary, Yates, Melinda S., primary, van der Hoeven, Dharini, primary, Rodkey, Travis L., primary, Zhang, Qian, primary, Co, Ngai Na, primary, Burzawa, Jennifer, primary, Chigurupati, Sravanthi, primary, Celestino, Joseph, primary, Bowser, Jessica, primary, Broaddus, Russell, primary, Hancock, John F., primary, Schmandt, Rosemarie, primary, and Lu, Karen H., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure 4 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Figure 3 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table 1 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table 2 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 3 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 2 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 2 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

16. Data from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 2 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure 4 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure Legend from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Table 3 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figure Legend from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 1 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 1 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure 3 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Table 1 from Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, primary, Thompson, Melissa S., primary, Leung, Cecilia S., primary, Harding, Tom, primary, Co, Ngai-Na, primary, Schmandt, Rosie S., primary, Kwan, Suet-Ying, primary, Rodriguez-Aguay, Cristian, primary, Lopez-Berestein, Gabriel, primary, Sood, Anil K., primary, Wong, Kwong-Kwok, primary, Birrer, Michael J., primary, and Mok, Samuel C., primary

Published
2023
Full Text
View/download PDF

29. Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy

Author

Iglesias, David A., primary, Yates, Melinda S., additional, van der Hoeven, Dharini, additional, Rodkey, Travis L., additional, Zhang, Qian, additional, Co, Ngai Na, additional, Burzawa, Jennifer, additional, Chigurupati, Sravanthi, additional, Celestino, Joseph, additional, Bowser, Jessica, additional, Broaddus, Russell, additional, Hancock, John F., additional, Schmandt, Rosemarie, additional, and Lu, Karen H., additional

Published
2013
Full Text
View/download PDF

31. Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Author

Zaid, Tarrik M., primary, Yeung, Tsz-Lun, additional, Thompson, Melissa S., additional, Leung, Cecilia S., additional, Harding, Tom, additional, Co, Ngai-Na, additional, Schmandt, Rosie S., additional, Kwan, Suet-Ying, additional, Rodriguez-Aguay, Cristian, additional, Lopez-Berestein, Gabriel, additional, Sood, Anil K., additional, Wong, Kwong-Kwok, additional, Birrer, Michael J., additional, and Mok, Samuel C., additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results